Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI ...

Understanding how the human immune system fights Plasmodium vivax paves the way for the first effective vaccine against it.

Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a ...

Jess Randall’s experience contracting malaria during a global health internship in rural Kenya has reshaped her career goals, inspiring her to focus on addressing health disparities through public hea ...

Malaria parasites contain tiny spinning crystals that have puzzled scientists for years. New research reveals they’re powered by a rocket-like reaction that breaks down hydrogen peroxide, releasing ...

Scientists have found that a special component in some people's blood provides them with natural protection against malaria. A recent study has demonstrated that a genetic variant named rs112233623-T ...

ICMR seeks industry partners for tech transfer of a NIMR-developed malaria test that detects species-specific Plasmodium, improving diagnosis, treatment, and malaria control in India.

Medicine to treat babies and infants suffering from malaria has been approved for the first time and is expected to be rolled out in Africa within weeks. Malaria treatment for infants weighing less ...

When floods sweep through southern Africa, the most visible damage is immediate: homes washed away, crops destroyed, clinics disrupted, families displaced. These images dominate headlines and ...

Each December, I mark the anniversary of my survival from cerebral malaria. That near-death encounter left me partially blind, profoundly changed and forever aware of the precarious nature of global ...